AWE
BDSX icon

Avidian Wealth Enterprises’s Biodesix BDSX Stock Holding History

Avidian Wealth Enterprises’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,500
Closed -$411K – 541
2021
Q3 		$411K Buy
2,500
+900
+56% +$171K 0.03% 245
2021
Q2 		$423K Buy
1,600
+350
+28% +$110K 0.03% 253
2021
Q1 		$508K Sell
1,250
-200
-14% -$89.3K 0.04% 209
2020
Q4 		$585K Buy
+1,450
New +$451K 0.06% 159

Other funds holding BDSX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Avidian Wealth Enterprises's BDSX Position: Q4 2021 in Review

Avidian Wealth Enterprises sold out of Biodesix (BDSX) in Q4 2021, closing a stake of 2,500 shares — an estimated $411K sold.

Avidian Wealth Enterprises first reported a position in BDSX in Q4 2020 and held it in 4 quarters. The position peaked at $585K in Q4 2020. 41 funds tracked by Wall St. Rank hold BDSX as of Q4 2021.

  • Avidian Wealth Enterprises reported no remaining Biodesix position as of Q4 2021 after selling out during the quarter.
  • Avidian Wealth Enterprises sold 2,500 Biodesix shares in Q4 2021, an estimated $411K.
  • Avidian Wealth Enterprises first reported a position in Biodesix in Q4 2020 and held it in 4 quarters.
  • Avidian Wealth Enterprises's Biodesix position peaked at $585K in Q4 2020.
  • 41 funds tracked by Wall St. Rank held Biodesix as of Q4 2021.

Based on Avidian Wealth Enterprises's 13F filing for Q4 2021, filed 14 Feb 2022.